Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin.
Saved in:
| Title: | Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin. |
|---|---|
| Authors: | BAIN, V. G.1 (AUTHOR), LEE, S. S.2 (AUTHOR), PELTEKIAN, K.3 (AUTHOR), YOSHIDA, E. M.4 (AUTHOR), DESCHÊNES, M.5 (AUTHOR), SHERMAN, M.6 (AUTHOR), BAILEY, R.7 (AUTHOR), WITT‐SULLIVAN, H.8 (AUTHOR), BALSHAW, R.9 (AUTHOR), KRAJDEN, M.10 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jul2008, Vol. 28 Issue 1, p43-50. 8p. 2 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 32470917 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22BAIN%2C+V%2E+G%2E%22">BAIN, V. G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22LEE%2C+S%2E+S%2E%22">LEE, S. S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22PELTEKIAN%2C+K%2E%22">PELTEKIAN, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22YOSHIDA%2C+E%2E+M%2E%22">YOSHIDA, E. M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22DESCHÊNES%2C+M%2E%22">DESCHÊNES, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22SHERMAN%2C+M%2E%22">SHERMAN, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22BAILEY%2C+R%2E%22">BAILEY, R.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22WITT‐SULLIVAN%2C+H%2E%22">WITT‐SULLIVAN, H.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22BALSHAW%2C+R%2E%22">BALSHAW, R.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22KRAJDEN%2C+M%2E%22">KRAJDEN, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Alimentary+Pharmacology+%26+Therapeutics%22">Alimentary Pharmacology & Therapeutics</searchLink>. Jul2008, Vol. 28 Issue 1, p43-50. 8p. 2 Charts, 3 Graphs. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=32470917 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/j.1365-2036.2008.03705.x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 43 Titles: – TitleFull: Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: BAIN, V. G. – PersonEntity: Name: NameFull: LEE, S. S. – PersonEntity: Name: NameFull: PELTEKIAN, K. – PersonEntity: Name: NameFull: YOSHIDA, E. M. – PersonEntity: Name: NameFull: DESCHÊNES, M. – PersonEntity: Name: NameFull: SHERMAN, M. – PersonEntity: Name: NameFull: BAILEY, R. – PersonEntity: Name: NameFull: WITT‐SULLIVAN, H. – PersonEntity: Name: NameFull: BALSHAW, R. – PersonEntity: Name: NameFull: KRAJDEN, M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 02692813 Numbering: – Type: volume Value: 28 – Type: issue Value: 1 Titles: – TitleFull: Alimentary Pharmacology & Therapeutics Type: main |
| ResultId | 1 |